An Exploratory, Randomized, Single Blinded, Placebo-Controlled, Dose-Ranging Study of the Safety and Efficacy of "MILNACIPRAN" in Subjects With Chronic Shoulder Pain

Trial Profile

An Exploratory, Randomized, Single Blinded, Placebo-Controlled, Dose-Ranging Study of the Safety and Efficacy of "MILNACIPRAN" in Subjects With Chronic Shoulder Pain

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Aug 2012

At a glance

  • Drugs Milnacipran (Primary)
  • Indications Shoulder pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Aug 2012 Actual end date (June 2011) added as reported by ClinicalTrials.gov.
    • 14 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top